Mouse mAb5E6 can improve drug efficacy by more accurately recognizing MUC16-CTER on the surface of tumor cells (the endogenous 114-amino acid carboxy-terminal fragment of MUC16 retained on the cell surface) [77]. This evidence concerns the gene MUC16 and neoplasm.